You may experience new or unexpected reactions, such as nausea, vomiting, diarrhea, constipation, fatigue, bloating, and headache
The positioning of BPC-157 within a longevity protocol reflects a broader philosophy: aging is not a single process but a convergence of declining repair capacity, accumulating cellular damage, and dysregulated signaling
Expression of xCT as a predictor of disease recurrence in patients with colorectal cancer
If it is not, he will tell you directly and suggest alternatives
Principal Investigator on A Randomized, Double-blind, Multicentre, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy. Principal Investigator on A Study of Disease Characteristics and Real-life Standard of Care Effectiveness in Patients with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including an SSRI or SNR. (Janssen)
Document BMI, counseling, and failed interventions consistently